ARPC1A and cancer: Our study leveraged public databases and bioinformatics tools to comprehensively explore the biological mechanisms of ARPC1A in a pan-cancer context, its association with the immune microenvironment and chemotherapy sensitivity, and its potential as a biomarker for predicting immunotherapy response.